EGI
GEN

EAM Global Investors’s Genesis Healthcare, Inc. GEN Stock Holding History

EAM Global Investors’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,091
Closed -$23K – 204
2018
Q2 		$23K Buy
+10,091
New +$19.5K 0.01% 147

Other funds holding GEN

CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

EAM Global Investors's GEN Position: Q3 2018 in Review

EAM Global Investors sold out of Genesis Healthcare, Inc. (GEN) in Q3 2018, closing a stake of 10,091 shares — an estimated $23K sold.

EAM Global Investors first reported a position in GEN in Q2 2018 and held it in 1 quarter. The position peaked at $23K in Q2 2018. 77 funds tracked by Wall St. Rank hold GEN as of Q3 2018.

  • EAM Global Investors reported no remaining Genesis Healthcare, Inc. position as of Q3 2018 after selling out during the quarter.
  • EAM Global Investors sold 10,091 Genesis Healthcare, Inc. shares in Q3 2018, an estimated $23K.
  • EAM Global Investors first reported a position in Genesis Healthcare, Inc. in Q2 2018 and held it in 1 quarter.
  • EAM Global Investors's Genesis Healthcare, Inc. position peaked at $23K in Q2 2018.
  • 77 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2018.

Based on EAM Global Investors's 13F filing for Q3 2018, filed 8 Nov 2018.